pharma · Weight Loss · Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD) · VKTX
Viking Therapeutics
NovaPharmaNews editorial coverage mentioning Viking Therapeutics — regulatory, clinical, and market analysis.
San Diego, USA HQ
2012 Founded
60 Employees
Public company Type
VKTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- San Diego, USA
- Founded
- 2012
- Employees
- 60
- Programs
- 6
- Drugs
- 3
- Patents
- 15
News & analysis
NovaPharmaNews articles mentioning Viking Therapeutics — regulatory, clinical, and market coverage.
NovaPharmaNews editorial coverage mentioning Viking Therapeutics — regulatory, clinical, and market analysis.